Clinical Neurology and Psychiatry
A section of Clinics and Practice (ISSN 2039-7283).
Section Information
The Clinical Neurology and Psychiatry section of Clinics and Practice provides an open access forum for clinical research and practice-oriented scholarship spanning the full spectrum of neurological and psychiatric conditions. With a strong translational and patient-centred focus, this section covers diagnosis, pharmacological and non-pharmacological treatment strategies, mental health service delivery, and clinical outcomes. A particular emphasis is placed on neuropsychiatric disorders, affective and psychotic conditions, treatment-resistant syndromes, neurodevelopmental and neurodegenerative diseases with behavioural manifestations, and the biological underpinnings of psychiatric illness. This section welcomes clinical trials, observational studies, systematic reviews, case reports, and perspectives that bridge evidence-based medicine with everyday practice.
Psychiatric disorders:
- Affective disorders and treatment-resistant depression;
- Psychotic disorders and schizophrenia spectrum conditions;
- Anxiety, OCD, and trauma- and stressor-related disorders;
- Addictive disorders and substance use;
- Eating disorders and somatic symptom disorders;
- Community mental health and psychiatric service delivery.
Neuropsychiatric and interface domains:
- Neurodevelopmental disorders (ADHD, autism spectrum disorder);
- Neurodegenerative diseases with neuropsychiatric manifestations;
- Alzheimer’s disease and other dementias;
- Consultation–liaison psychiatry and neuropsychiatry;
- Sleep disorders in neurological and psychiatric practice;
- Geriatric psychiatry and late-life neuropsychiatric conditions;
- Child and adolescent neuropsychiatry;
- Psychopharmacology and clinical drug management;
- Neuromodulation and brain stimulation therapies (TMS, ECT, tDCS);
- Digital health technologies and digital assessment in psychiatry.
Neurological disorders:
- Epilepsy and seizure disorders;
- Headache and pain disorders;
- Multiple sclerosis and neuroimmunological conditions;
- Movement disorders and Parkinson’s disease;
- Cerebrovascular diseases and stroke rehabilitation;
- Neurorehabilitation and functional recovery.
Special Issue
Following special issue within this section is currently open for submissions:
- Early Diagnosis and Emerging Therapies in Cerebrovascular Disorders (Deadline: 15 July 2027)
